These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 29554887)

  • 21. Diagnostic accuracy of osteopontin plus alpha-fetoprotein in the hepatocellular carcinoma: A meta-analysis.
    Li J; Chen X; Dai M; Huang S; Chen J; Dai S
    Clin Res Hepatol Gastroenterol; 2017 Oct; 41(5):543-553. PubMed ID: 28291627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic Accuracy of Serum/Plasma Circular RNAs and the Combination of Circular RNAs and α-Fetoprotein for Detecting Hepatocellular Carcinoma: A Meta-Analysis.
    Nie G; Peng D; Li B; Lu J; Cai Y; Xiong X; Cheng N
    Front Genet; 2021; 12():722208. PubMed ID: 34659344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic value of RNA for hepatocellular carcinoma: a network meta-analysis.
    Han Z; Li K; Wu J; Wang K; Qiu C; Ye H; Cui C; Song C; Wang K; Shi J; Wang P; Zhang J
    Biomark Med; 2021 Dec; 15(18):1755-1767. PubMed ID: 34783583
    [No Abstract]   [Full Text] [Related]  

  • 24. Diagnostic performance of circular RNAs in human cancers: A systematic review and meta-analysis.
    Li J; Li H; Lv X; Yang Z; Gao M; Bi Y; Zhang Z; Wang S; Cui Z; Zhou B; Yin Z
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00749. PubMed ID: 31106993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of quantitative and qualitative analyses of circulating cell-free DNA as diagnostic tools for hepatocellular carcinoma: a meta-analysis.
    Liao W; Mao Y; Ge P; Yang H; Xu H; Lu X; Sang X; Zhong S
    Medicine (Baltimore); 2015 Apr; 94(14):e722. PubMed ID: 25860220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Circulatory RNA-Based Biomarker Panel in Hepatocellular Carcinoma.
    El-Tawdi AH; Matboli M; Shehata HH; Tash F; El-Khazragy N; Azazy Ael-S; Abdel-Rahman O
    Mol Diagn Ther; 2016 Jun; 20(3):265-77. PubMed ID: 27113935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The diagnostic significance of blood-derived circRNAs in NSCLC: Systematic review and meta-analysis.
    Yu W; Liu R; Miao Z; Zhang L; Sheyhidin I; Ainiwaer J
    Front Oncol; 2022; 12():987704. PubMed ID: 36353543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic and prognostic value of circular RNAs in hepatocellular carcinoma.
    Sun JY; Zhang XY; Cao YZ; Zhou X; Gu J; Mu XX
    J Cell Mol Med; 2020 May; 24(10):5438-5445. PubMed ID: 32281724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using circular RNA as a novel type of biomarker in the screening of gastric cancer.
    Li P; Chen S; Chen H; Mo X; Li T; Shao Y; Xiao B; Guo J
    Clin Chim Acta; 2015 Apr; 444():132-6. PubMed ID: 25689795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Diagnostic Value of MicroRNAs as a Biomarker for Hepatocellular Carcinoma: A Meta-Analysis.
    Jiang Y; He J; Li Y; Guo Y; Tao H
    Biomed Res Int; 2019; 2019():5179048. PubMed ID: 31871941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive analysis of circRNA expression profiles in humans by RAISE.
    Li L; Zheng YC; Kayani MUR; Xu W; Wang GQ; Sun P; Ao N; Zhang LN; Gu ZQ; Wu LC; Zhao HT
    Int J Oncol; 2017 Dec; 51(6):1625-1638. PubMed ID: 29039477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormally expressed circular RNAs as novel non-invasive biomarkers for hepatocellular carcinoma: A meta-analysis.
    Jiang YL; Shang MM; Dong SZ; Chang YC
    World J Gastrointest Oncol; 2019 Oct; 11(10):909-924. PubMed ID: 31662829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitivity and specificity of Dickkopf-1 protein in serum for diagnosing hepatocellular carcinoma: a meta-analysis.
    Zhang J; Zhao Y; Yang Q
    Int J Biol Markers; 2014 Dec; 29(4):e403-10. PubMed ID: 24980448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic accuracy of midkine for hepatocellular carcinoma: A meta-analysis.
    Zhang Y; Tang J; Zhou X; Zhu SL; Li LQ
    Mol Genet Genomic Med; 2020 Feb; 8(2):e1071. PubMed ID: 31777190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic value of circular RNAs as effective biomarkers for cancer: a systematic review and meta-analysis.
    Tan H; Gan L; Fan X; Liu L; Liu S
    Onco Targets Ther; 2019; 12():2623-2633. PubMed ID: 31114221
    [No Abstract]   [Full Text] [Related]  

  • 36. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
    Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z
    Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic value of circular RNAs in colorectal cancer: A systematic review and meta-analysis.
    Zhao Z; Zhao Y; Liu Y; Zou J; Zhu Y
    Pathol Res Pract; 2019 Dec; 215(12):152680. PubMed ID: 31635986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential Role of Circulating microRNA-21 for Hepatocellular Carcinoma Diagnosis: A Meta-Analysis.
    Liao Q; Han P; Huang Y; Wu Z; Chen Q; Li S; Ye J; Wu X
    PLoS One; 2015; 10(6):e0130677. PubMed ID: 26114756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CircRNAs as promising biomarker in diagnostic and prognostic of lung cancer: An updated meta-analysis.
    Yang X; Tian W; Wang S; Ji X; Zhou B
    Genomics; 2021 Jan; 113(1 Pt 1):387-397. PubMed ID: 33326833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computational identifying and characterizing circular RNAs and their associated genes in hepatocellular carcinoma.
    Li Y; Dong Y; Huang Z; Kuang Q; Wu Y; Li Y; Li M
    PLoS One; 2017; 12(3):e0174436. PubMed ID: 28346469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.